Balyasny Asset Management »

Carmell Therapeutics Corp - US shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Carmell Therapeutics Corp - US (CTCXW) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Carmell Therapeutics Corp - US

Tip: Access up to 7 years of quarterly data

All positions including Carmell Therapeutics Corp - US held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Carmell Therapeutics Corp - US by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $79k 343k 0.23
2023-09-30 $86k 343k 0.25

More positions owned by Balyasny Asset Management

Ishares Tr Russell 2000 Etf (IWM)
Microsoft Corporation Call Option (MSFT)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Select Sector Spdr Tr Financial (XLF)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Hess Put Option (HES)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Amazon (AMZN)
JPMorgan Chase & Co. Call Option (JPM)
Ishares Tr Core S&p Mcp Etf (IJH)
Union Pacific Corporation Call Option (UNP)
Select Sector Spdr Tr Technology (XLK)
Boeing Company (BA)
Deere & Company (DE)

View all positions for Balyasny Asset Management

Top funds holding Carmell Therapeutics Corp - US

Balyasny Asset Management
Millennium Management
OZ Management
Highbridge Capital Management
Exos TFP Holdings
CNH Partners
Walleye Trading Advisors
Cowen And Company
Flow Traders US
Saba Capital Management
Whitebox Advisors
Wolverine Asset Management
Ancora Advisors

View all funds holding Carmell Therapeutics Corp - US